Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Acta Psychiatrica Scandinavica|January 21, 2006
Standardized remission criteria in schizophreniaJ van Os, T Burns, R Cavallaro, et al.
Schizophrenia Bulletin|June 23, 2009
Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trialK P Grootens, N M J van Veelen, J Peuskens, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 14, 2010
Effects on cognitive functioning after olanzapine-ziprasidone crossover in recent-onset schizophreniaK P Grootens, N M J van Veelen, M M Sitskoorn, et al.
Schizophrenia Research|May 25, 2010
Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophreniaNicoletta M J van Veelen, Koen P Grootens, J Peuskens, et al.
Laterality|March 6, 2012
Familial sinistrality and handedness in patients with first episode schizophrenia: the EUFEST studyS Dollfus, M Alary, A Razafimandimby, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 8, 2010
Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidoneM A Crocq, D Naber, M H Lader, et al.
Acta Psychiatrica Scandinavica|April 14, 2010
Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)S H L Thomas, M D Drici, G C Hall, et al.
Schizophrenia Research|March 30, 2013
Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST studyT Wobrock, P Falkai, T Schneider-Axmann, et al.
Pageof 8